Interested in Making an Extra $10,000 Every month for Your Practice?
Modern Health Care Professional

Genomics

Pure Encapsulations® Expands PureGenomics® Platform with New Resources to Facilitate Precision Nutrition

06.25.14_Pure_Encapsulations_logoSUDBURY, Mass., July 18, 2016 /PRNewswire/ – Within every patient’s genome are opportunities to optimize health and wellness. Today, Pure Encapsulations® announces the addition of the Antioxidant & Cellular Defense Protocol to its PureGenomics® platform, enabling practitioners to evaluate patients’ genetic makeup and tailor nutritional supplement regimens that help bypass specific genetic variations, leading to optimized antioxidant status, detoxification and estrogen metabolism.*

PureGenomics combines educational tools, protocols and core products with a dynamic, practitioner-exclusive website application to help identify and address common genetic variations known as Single Nucleotide Polymorphisms (SNPs). The new Antioxidant & Cellular Defense Protocol, developed read more…

VIDEO: Dr. Jeffrey Bland Interviews Elizabeth Parrish on Gene Therapy

Dr.Jeffrey Bland interviews Elizabeth Parrish, CEO of BioViva, about one aspect of where health care will be heading in the 21st century. BioViva is a biotech company in the Seattle area focused on researching and developing gene therapy for anti-aging. These ground-breaking gene therapies have an impact on all age-related disease, including cancers, heart disease, muscle atrophy, Alzheimer’s disease, dementia, and more.

Learn more about the direction of gene therapy, some specific gene therapies BioViva is working on, and some of the research results in this video interview by Dr. Jeffry Bland,  nationally recognized leader in nutritional medicine read more…

Dr Jeffrey Bland: Is Genomics the Future of Cancer Care?

Many aspects of cancer treatment today are beginning to take a more holistic approach to treatment. In this fourth installment of the Functional Medicine & Genomics series, Dr. Jeffrey Bland discusses recent innovations in cancer treatment, and looks at this complex category of diseases from the perspective of genomics.

Including several additional resources, including audio interviews with Thomas Brown, MD, MBA, of the Swedish Cancer Institute, and Michael Fenech, PhD, CSIRO, of Human Nutrition, Australia.

GeomicsandCancer read more…

Dr. Jeffrey Bland Discusses Whether Genomic Testing is Ready for Prime Time

In this third installment of the 6-part series on Functional Medicine and Genomics in partnership with the the Institute for Functional Medicine, Dr. Jeffrey Bland discusses the value of genomic testing, and how genomic tools can be used to promote health.

At the end of the article Dr. Bland provides several additional resources, including an interview with Eric Schadt, PhD, Director of the Icahn Institute for Genomics and Multiscale Biology, Mount Sinai Hospital. Click the link below to read the article.

DrBlandSeptImage read more…

Dr. Jeffrey Bland: Medicine for the Average Becomes Medicine for the Individual

In this second installment of the 6-part series on Functional Medicine and Genomics in partnership with the the Institute for Functional Medicine, Dr. Jeffrey Bland discusses how a medical system that has historically viewed human biology in terms of averages is now coming to utilize clinical genomics as the standard of medicine.  At the end of the article Dr. Bland provides several additional resources, including an interview with Lee Hood, MD, PhD, President and Co-founder of the Institute for Systems Biology – See more at: https://functionalmedicine.org/What_is_Functional_Medicine/AboutFM/Genomics/August/#sthash.xQIcEyLM.dpuf 

 

 

 

OmicsPart2Banner read more…

© 2017 Modern Healthcare Professional. All Rights Reserved.